Form 4: Hyperfine Director Dan Wolterman Receives Stock Options

Director Dan Wolterman was granted 52,600 stock options in Hyperfine, Inc. as part of his compensation package.

Summary

• Director Dan Wolterman acquired 52,600 stock options in Hyperfine, Inc. (HYPR).
• The options have an exercise price of $1.49 per share.
• The grant date for these options is June 3, 2026.
• The options are set to expire on June 3, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential future dilution of existing shareholders upon the exercise of these options.

Risks

• Vesting is contingent upon continued service through the date of the next annual stockholders meeting.

Future Outlook

The options vest on the date of the Issuer's next regular annual stockholders meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure board members have 'skin in the game' regarding company performance.

Comparison to Industry Standards

• The grant of stock options to directors is a common practice among mid-cap and small-cap technology and healthcare companies to attract and retain board talent.
• The vesting schedule tied to the annual meeting is a standard industry practice for director compensation.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options at the next annual stockholders meeting.

Key Dates

Keywords

Hyperfine, HYPR, Director, Stock Options, Insider Trading, SEC Form 4